Bajaj Electrical shines on back of Q3 results Bajaj Electrical shines on back of Q3 results Amir Shaikh / Thursday, February 7, 2019 / Article rating: 5.0 The PAT for the quarter came in at Rs. 63.92 crore, yoy increase of 73.6 per cent. Finance cost for the quarter jumped 132 per cent yoy to Rs. 33.3 crore.
How India's credibility is at stake in the crypto world? How India's credibility is at stake in the crypto world? DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 3.8 Much of the bitcoin, cryptocurrency frenzy had fizzled out in 2018, but many investors or so-called early adopters still hold hope in the phenomenon dubbed as the currency of the digital age. Now there is a major twist in the cryptocurrency tale and all that happened very close to us, read on to know.
Manappuram Q3 net profit up 42 per cent, stock gains Manappuram Q3 net profit up 42 per cent, stock gains DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 Manappuram Finance Limited has declared a good set of numbers for third quarter FY19. Shares of Mannappuram reached an intraday high of Rs. 104.15 per share on the BSE on Thursday.
Is the thumb rule 100 minus age relevant today? Is the thumb rule 100 minus age relevant today? DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 In asset allocation, 100 minus age is one of the basic thumb rules. Let’s find out if this rule is valid in today’s circumstances?
CIPLA receives approval from US FDA CIPLA receives approval from US FDA DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 Cipla’s Tadalafil Tablets 20mg is AB-rated generic therapeutic equivalent version of Eli Lilly’s Adcirca. It is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability.
Glenmark receives tentative approval for Fulvestrant Inj Glenmark receives tentative approval for Fulvestrant Inj DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 Pharma major Glenmark was granted tentative USFDA approval for Fulvestrant Injection, 250 mg/5 ml. The shares of the company experienced volatility on an intraday basis.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Thursday, February 7, 2019 / Article rating: 5.0 Following stocks are close to their 52-week low as at 2.36 p.m. on February 7, 2019.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Thursday, February 7, 2019 / Article rating: 3.5 The markets on February 7, 2019 opened gap up. BSE Sensex is trading at 37,108.42, up by 133.19 points and the Nifty is trading at 11,099.80, up by 37.35 points.
RBI cuts repo rate by 25bps RBI cuts repo rate by 25bps DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 The Reserve Bank of India (RBI) reduced policy repo rates under LAF by 25 basis points on Thursday. The Monetary Policy Committee (MPC) also changed its policy stance to neutral.
RBI unlikely to surrender to governments demand RBI unlikely to surrender to governments demand DSIJ Intelligence / Thursday, February 7, 2019 / Article rating: 5.0 A sum of Rs. 27,330 crore i.e. Rs. 13,140 crore in FY17 and Rs. 14,190 crore in FY18 was kept aside by the RBI for the contingency fund.